Why is Solara Active falling/rising?

As of 04-Aug, Solara Active Pharma Sciences Ltd is experiencing a price increase, currently at 615.45, reflecting a rise of 11.05 or 1.83%. The stock has shown a trend reversal today, gaining after two consecutive days of decline. It outperformed its sector by 1.49% and reached an intraday high of Rs 622.95. Despite a negative return of -10.62% over the past year, the company has reported positive results for the last four consecutive quarters, with a significant growth in net sales of 16.9%. However, the stock's long-term fundamentals are concerning, as it has a -7.45% CAGR growth in operating profits over the last five years and a high debt to EBITDA ratio of 6.20 times, which may limit its ability to service debt.
In the broader market context, the stock's performance over the past week shows a decline of -6.11%, while the benchmark Sensex has increased by 0.16%. This indicates that Solara Active is underperforming relative to the market in the short term. Despite the recent positive price movement, the overall trend suggests that investor sentiment may still be cautious due to the high proportion of pledged promoter shares and the company's weak long-term fundamental strength. The stock's attractive valuation compared to peers and its recent operational improvements may provide some support, but the underlying issues could continue to weigh on its performance in the longer term.